Glycosylation of Escherichia coli L-asparaginase.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 334766)

Published in J Biol Chem on November 10, 1977

Authors

J W Marsh, J Denis, J C Wriston

Articles by these authors

(truncated to the top 100)

Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science (2001) 3.02

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

L-asparaginase: a review. Adv Enzymol Relat Areas Mol Biol (1973) 2.56

The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol (2001) 2.23

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22

Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol (1994) 2.17

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99

HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A (1999) 1.92

Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90

The isolation of porcine ribonuclease, a glycoprotein, from pancreatic juice. J Biol Chem (1968) 1.83

Study of fifteen respirable aerosol samplers used in occupational hygiene. Ann Occup Hyg (2001) 1.80

Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73

Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J Virol (1996) 1.69

Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant (2009) 1.59

The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J Virol (1992) 1.58

Partial purification and antilymphoma activity of Serratia marcescens L-asparaginase. Biochem Biophys Res Commun (1967) 1.55

Should hepatomas be treated with hepatic resection or transplantation? Cancer (1999) 1.54

Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol (2008) 1.53

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

[Idiopathic portal hypertension associated with connective tissue disease similar to systemic lupus erythematosus]. Gastroenterol Clin Biol (1989) 1.39

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36

OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc (1987) 1.35

Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33

Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet (1990) 1.25

Surgical management of leiomyosarcoma of the inferior vena cava. J Gastrointest Surg (2008) 1.24

Experience with primary liver transplantation across ABO blood groups. Transplant Proc (1987) 1.23

ICRP Publication 115. Lung cancer risk from radon and progeny and statement on radon. Ann ICRP (2010) 1.21

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol (1998) 1.20

Adult to adult living-related liver transplant: report on an initial experience in Italy. Dig Liver Dis (2007) 1.16

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation (1999) 1.14

Transplantation for primary biliary cirrhosis. Gastroenterology (1988) 1.12

Liver transplantation in the treatment of bleeding esophageal varices. Surgery (1988) 1.11

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B. J Hepatol (2001) 1.09

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut (1978) 1.07

Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology (1992) 1.06

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology (1990) 1.05

FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05

The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139. Infect Immun (1998) 1.02

Coeliac disease in chronic hepatitis C: a French multicentre prospective study. Aliment Pharmacol Ther (2007) 1.02

Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology (2000) 1.01

HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J Biol Chem (1994) 1.01

IMBA Expert: internal dosimetry made simple. Radiat Prot Dosimetry (2003) 1.01

Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy. J Ocul Pharmacol (1994) 1.00

Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg (1989) 0.99

Liver transplantation for fulminant hepatic failure. Transplant Proc (1989) 0.98

Modelling particle retention in the alveolar-interstitial region of the human lungs. J Radiol Prot (2010) 0.98

Mycotic pseudoaneurysm of the gastroduodenal artery--an unusual cause of lower gastrointestinal tract hemorrhage following liver transplantation. Transplantation (1988) 0.97

Effective dose from inhaled radon and its progeny. Ann ICRP (2012) 0.96

Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab. Transpl Infect Dis (2007) 0.95

Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95

Purification and properties of guinea pig serum asparaginase. Biochemistry (1966) 0.95

Influence of incorporated cerebrosides on the interaction of liposomes with HeLa cells. Biochim Biophys Acta (1977) 0.95

Quantitative micro P30 and reverse transcriptase assays for Moloney murine leukemia virus. J Virol Methods (1994) 0.95

Is multiple organ failure a contraindication for liver transplantation in children? Transplant Proc (1987) 0.95

HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. J Biol Chem (2001) 0.94

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study. Endoscopy (2012) 0.94

Purification and properties of asparaginase from escherichia coli B. Biochemistry (1969) 0.93

Laparoscopic major hepatectomy: pure laparoscopic approach versus hand-assisted technique. J Hepatobiliary Pancreat Sci (2013) 0.92

Obstructing mucocele of the cystic duct after transplantation of the liver. Surg Gynecol Obstet (1989) 0.92

[Diagnosis of spontaneous ascites infection in patients with cirrhosis: reagent strips]. Presse Med (2005) 0.92

Mortality from internal and external radiation exposure in a cohort of male German uranium millers, 1946-2008. Int Arch Occup Environ Health (2014) 0.92

Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Diabetes (1980) 0.92

Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology (1991) 0.92

HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement. J Immunol (1994) 0.91

Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology (1983) 0.91

Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery (1991) 0.91

Fine structure of palpebral molluscum contagiosum and its secondary conjunctival lesions. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 0.91

Antagonism of purified asparaginase from guinea pig serum toward lymphoma. Science (1966) 0.90

Surgical experience with hepatic colorectal metastasis. Am Surg (1999) 0.90

Asparaginase. Methods Enzymol (1985) 0.90

Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology (2001) 0.90

Assessment of intakes and doses to workers followed for 15 years after accidental inhalation of 60CO. Health Phys (2007) 0.90

Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut (2002) 0.89

Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology (1996) 0.89

Safety of liver resection in the elderly: how important is age? Ann Surg Oncol (2010) 0.88

Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation (1987) 0.87

Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids. CRC Crit Rev Biochem (1981) 0.87

Purification and properties of Bacillus coagulans L-asparaginase. Arch Biochem Biophys (1971) 0.87

Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology. Eur J Clin Microbiol Infect Dis (2007) 0.86

An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX. Toxicology (2008) 0.86

[Bi-directional ventricular tachycardia and pheochromocytoma: a case report]. Arch Mal Coeur Vaiss (2006) 0.85

Purification and properties of an L-asparaginase from Fusarium tricinctum. Arch Biochem Biophys (1971) 0.85

Change in hepatic function, hemodynamics, and morphology after liver transplant. Physiological effect of therapy. Ann Surg (1989) 0.85

Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them. Curr Pharm Des (2007) 0.84

Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J Neurochem (1983) 0.84

Progress in liver transplantation. Adv Surg (1988) 0.83

Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transplant (2015) 0.83

Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest (1993) 0.83

Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection? Transpl Int (1988) 0.83

Change in ribonuclease concentrations in L-asparaginase-treated lymphosarcomata. Nature (1966) 0.83

[Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation]. Presse Med (1983) 0.82

Chemical evidence for identical subunits in L-asparaginase from Escherichia coli B. Arch Biochem Biophys (1972) 0.82

A safe immunosuppressive protocol in adult-to-adult living related liver transplantation. Transplant Proc (2006) 0.82

Particle clearance in the alveolar-interstitial region of the human lungs: model validation. Radiat Prot Dosimetry (2010) 0.82

Screening for cerebral aneurysm in patients with polycystic liver disease. South Med J (1999) 0.81

Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc (1996) 0.81

[Hydatid cyst of the interventricular septum. Apropos of a case]. Arch Mal Coeur Vaiss (1994) 0.81

Successful retransplantation after a 48-hour anhepatic state. Transplant Proc (1993) 0.81

Survival after liver transplantation in patients with hepatocellular carcinoma. Princess Takamatsu Symp (1995) 0.81